A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency
Clinical trial NCT03378531 · COMPLETED
Trial details
- NCT number
- NCT03378531
- Sponsor
- Aeglea Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-07
- Primary completion
- 2022-12-15
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.